DBV Technologies Stock (NASDAQ: DBVT) stock price, news, charts, stock research, profile.
Open | $1.02 |
Close | $0.93 |
Volume / Avg. | 16.29K / 80.42K |
Day Range | 0.93 - 1.02 |
52 Wk Range | 0.50 - 7.40 |
Market Cap | $90.46M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | - |
Days to Cover | 6.5 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB) and Armata Pharmaceuticals (AMEX:ARMP).
There is no analysis for DBV Technologies.
DBV Technologies has a consensus price target of $3.33.
The stock price for DBV Technologies (NASDAQ: DBVT) is $0.94 last updated July 25, 2024 at 8:54 AM EDT.
There are no upcoming dividends for DBV Technologies.
DBV Technologies’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.